By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Entest Biomedical, Inc. 



San Diego  California    U.S.A.
Phone: n/a Fax:


SEARCH JOBS


Industry
Medical Device






Company News
Entest Biomedical, Inc.'s Chairman Discusses Its Subsidiary, Zander Therapeutics, Inc.'s Progress With Small Molecule Immunotherapies For Treating Cancer And Arthritis In Dogs 4/27/2017 11:55:43 AM
Entest Biomedical, Inc.'s Subsidiary, Zander Therapeutics, Inc., Initiates Ex Vivo Studies On Modulating NR2F6 In Canines 4/19/2017 8:32:03 AM
Entest Biomedical, Inc.'s Subsidiary Zander Therapeutics, Inc. Announces Appointment Of Dr. Thomas Donnelly To Serve As Senior Veterinary Advisor 3/9/2017 11:38:14 AM
Entest Biomedical, Inc.'s Zander Therapeutics, Inc. Unit Announces Publication Of Canine Cellular Immunotherapy Patent Application For Treating Cancer In Dogs 2/15/2017 6:43:37 AM
Entest Biomedical, Inc.'s Subsidiary Zander Therapeutics Makes Key Additions To Management Team As The Company Prepares To Move Forward In The $63 Billion Veterinary / Pet Market Niche 2/6/2017 9:06:32 AM
Entest Biomedical, Inc. Chairman David Koos Discusses Zander Therapeutics Subsidiary And Future Plans For The Company Moving Into 2017 12/27/2016 9:52:03 AM
Entest Biomedical, Inc.'s Zander Therapeutics Unit Files Composition Of Matter Patent On NR2F6 Modulating Small Molecules In Canine And Feline Applications 10/20/2016 10:44:46 AM
Entest Biomedical, Inc.'s Zander Therapeutics Unit Files Patent Application On Ex Vivo Activated Autologous Immune Cells 8/11/2015 6:57:22 AM
Entest Biomedical, Inc.'s Zander Therapeutics Unit: Initial Focus Is Small Molecule And Cancer Stem Targeting For Veterinary Oncology 8/4/2015 8:32:45 AM
Entest Biomedical, Inc. In Discussions To Acquire Nanotechnology Delivery System For Cancer Therapy 6/2/2015 10:45:27 AM
1234567
//-->